Different Brain Regions are Infected with Fungi in Alzheimer’s Disease

The possibility that Alzheimer’s disease (AD) has a microbial aetiology has been proposed by several researchers. Here, we provide evidence that tissue from the central nervous system (CNS) of AD patients contain fungal cells and hyphae. Fungal material can be detected both intra- and extracellularly using specific antibodies against several fungi. Different brain regions including external frontal cortex, cerebellar hemisphere, entorhinal cortex/hippocampus and choroid plexus contain fungal material, which is absent in brain tissue from control individuals. Analysis of brain sections from ten additional AD patients reveals that all are infected with fungi. Fungal infection is also observed in blood vessels, which may explain the vascular pathology frequently detected in AD patients. Sequencing of fungal DNA extracted from frozen CNS samples identifies several fungal species. Collectively, our findings provide compelling evidence for the existence of fungal infection in the CNS from AD patients, but not in control individuals.

[1]  R. Castellani,et al.  The role of novel chitin-like polysaccharides in Alzheimer disease , 2007, Neurotoxicity Research.

[2]  J. Guarro,et al.  Developments in Fungal Taxonomy , 1999, Clinical Microbiology Reviews.

[3]  Ruth F. Itzhaki,et al.  Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus , 2014, Front. Aging Neurosci..

[4]  G. Perry,et al.  Chitin-like polysaccharides in Alzheimer's disease brains. , 2005, Current Alzheimer research.

[5]  A. Biswas,et al.  Reactive oxygen species, redox signaling and neuroinflammation in Alzheimer's disease: the NF-κB connection. , 2015, Current topics in medicinal chemistry.

[6]  D. Gozalbo,et al.  Role of IFN-gamma in immune responses to Candida albicans infections. , 2014, Frontiers in bioscience.

[7]  K. Suk,et al.  Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease , 2011, Journal of Neurology.

[8]  Infectious Agents and Neurodegeneration , 2012, Molecular Neurobiology.

[9]  Simone Lista,et al.  Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future , 2015, Expert review of neurotherapeutics.

[10]  Gabriel Gold,et al.  Alzheimer disease therapy—moving from amyloid-β to tau , 2013, Nature Reviews Neurology.

[11]  S. Sotgiu,et al.  Different content of chitin-like polysaccharides in multiple sclerosis and Alzheimer's disease brains , 2008, Journal of Neuroimmunology.

[12]  A. Rivera,et al.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation. , 2012, Cytokine.

[13]  M. Hoffmann,et al.  Cryptococcal meningitis misdiagnosed as Alzheimer's disease: complete neurological and cognitive recovery with treatment. , 2009, Journal of Alzheimer's disease : JAD.

[14]  E. Mylonakis,et al.  Fungal central nervous system infections: prevalence and diagnosis , 2014, Expert review of anti-infective therapy.

[15]  Luis Carrasco,et al.  Direct visualization of fungal infection in brains from patients with Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[16]  R. Doss,et al.  Reversible dementia: a case of cryptococcal meningitis masquerading as Alzheimer's disease. , 2004, Journal of Alzheimer's disease : JAD.

[17]  F. Sohrabji,et al.  Vascular and metabolic dysfunction in Alzheimer's disease: a review , 2011, Experimental biology and medicine.

[18]  Mohammad A Kamal,et al.  Link between chronic bacterial inflammation and Alzheimer disease. , 2014, CNS & neurological disorders drug targets.

[19]  Luis Carrasco,et al.  Alzheimer’s disease and disseminated mycoses , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[20]  G. Pawelec.  Extrathymic T-cell differentiation in vitro , 2004, Nature Reviews Immunology.

[21]  David S Younger,et al.  Vasculitis of the nervous system , 2004, Current opinion in neurology.

[22]  K. Kim.  Microbial translocation of the blood-brain barrier. , 2006, International journal for parasitology.

[23]  Luis Carrasco,et al.  Fungal infection in patients with Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[24]  D. Andes.  Optimizing antifungal choice and administration , 2013, Current medical research and opinion.

[25]  J. Miklossy,et al.  Chronic inflammation and amyloidogenesis in Alzheimer's disease -- role of Spirochetes. , 2008, Journal of Alzheimer's disease : JAD.

[26]  D. Lomas,et al.  Endoplasmic reticulum dysfunction in neurological disease , 2013, The Lancet Neurology.

[27]  Luis Carrasco,et al.  Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis , 2015, International journal of biological sciences.

[28]  Martin Ingelsson,et al.  The Alzheimer's Disease-Associated Amyloid \(\beta\)-Protein Is an Antimicrobial Peptide , 2010 .

[29]  I. Knuesel,et al.  Deciphering the mechanism underlying late-onset Alzheimer disease , 2013, Nature Reviews Neurology.

[30]  S. Finegold,et al.  Vasculitides associated with infections, immunization, and antimicrobial drugs. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  S. Balusu,et al.  Establishment of an in vitro system to study intracellular behavior of Candida glabrata in human THP-1 macrophages. , 2013, Journal of visualized experiments : JoVE.

[32]  R. Maccioni,et al.  Neuroimmunomodulation in the Pathogenesis of Alzheimer’s Disease , 2010, Neuroimmunomodulation.

[33]  P. Grammas,et al.  Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[34]  G. Ricevuti,et al.  Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. , 2011, Autoimmunity reviews.

[35]  N. Cairns,et al.  Novel Types of Frontotemporal Lobar Degeneration: Beyond Tau and TDP-43 , 2011, Journal of Molecular Neuroscience.

[36]  Claudio Soto,et al.  Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.

[37]  C. Joukhadar,et al.  Efficacy and Safety of Current Drug Therapies for Invasive Aspergillosis , 2011, Pharmacology.

[38]  K. Blennow,et al.  Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease , 2014, Dementia and Geriatric Cognitive Disorders Extra.

[39]  A. Casadevall,et al.  The intracellular life of Cryptococcus neoformans. , 2014, Annual review of pathology.

[40]  P. Agostinho,et al.  Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[41]  M. Cesari,et al.  Proinflammatory cytokines, aging, and age-related diseases. , 2013, Journal of the American Medical Directors Association.

[42]  R. Akinyemi,et al.  Does vascular pathology contribute to Alzheimer changes? , 2012, Journal of the Neurological Sciences.

[43]  R. Tanzi.  The synaptic Aβ hypothesis of Alzheimer disease , 2005, Nature Neuroscience.

[44]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[45]  M. D'Angelo,et al.  Age-Dependent Deterioration of Nuclear Pore Complexes Causes a Loss of Nuclear Integrity in Postmitotic Cells , 2009, Cell.

[46]  D. Pisa,et al.  Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[47]  R. Tanzi.  The synaptic Abeta hypothesis of Alzheimer disease. , 2005, Nature neuroscience.

[48]  D. Appelt,et al.  Infiltration of the brain by pathogens causes Alzheimer’s disease , 2004, Neurobiology of Aging.

[49]  J. Jhamandas,et al.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. , 2013, Journal of psychiatry & neuroscience : JPN.

[50]  Luis Carrasco,et al.  Attachment and entry of Candida famata in monocytes and epithelial cells , 2007, Microscopy research and technique.

[51]  J. Bockaert,et al.  Alzheimer culprits: cellular crossroads and interplay. , 2012, Cellular signalling.

[52]  H A Kestler,et al.  Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease , 2012, Neurology.

[53]  Ottavio Arancio,et al.  Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? , 2012, The Biochemical journal.

[54]  S. Smeekens,et al.  Genetic susceptibility to Candida infections , 2013, EMBO molecular medicine.

[55]  Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics , 2014, Molecular Neurodegeneration.

[56]  G. Eslick,et al.  BACTERIAL INFECTION AND ALZHEIMER'S DISEASE: A META-ANALYSIS , 2014, Alzheimer's & Dementia.

[57]  M. Netea,et al.  Mendelian genetics of human susceptibility to fungal infection. , 2014, Cold Spring Harbor Perspectives in Medicine.

[58]  R. Bellmann.  Pharmacodynamics and pharmacokinetics of antifungals for treatment of invasive aspergillosis. , 2013, Current pharmaceutical design.

[59]  B. Hyman,et al.  The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.

[60]  J. Woulfe,et al.  Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress , 2007, Neuropathology and applied neurobiology.

[61]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[62]  L. Romani.  Immunity to fungal infections , 2004, Nature Reviews Immunology.

[63]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.